Rumors of Baxter's $4B Gambro buyout prove true

Tue, 12/04/2012 - 4:00pm
Mass Device

Baxter confirms rumors by announcing that it signed a definitive agreement to acquire Swedish dialysis devices maker Gambro AB for a total of about $4 billion.

mergers and acquisitions illustration

Rumors circulating late last month proved true with Baxter (NYSE:BAX) this week announced that it had signed a $4 billion (26.5 billion SEK) merger agreement with Swedish dialysis Gambro.

The deal, to be paid through a combination of cash and deb, gives Baxter a strong foothold in the dialysis devices arena and complements the company's existing home dialysis product portfolio, the company noted.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.